Compounded medications are not FDA approved and carry risks related to inconsistent potency, sterility, and formulation quality
CJC-1295 No DAC is a 29-amino-acid modified GRF(1-29) sequence with D-Ala, Gln, Ala, and Leu substitutions designed to resist DPP-IV cleavage, offering a shorter pulsatile pharmacokinetic profile compared to the DAC-linked variant
The post says women with a personal or family history of thyroid cancer, multiple endocrine neoplasia type 2, uncontrolled diabetes complications, or certain cardiovascular conditions require careful medical clearance
Relevant to laboratory investigations involving pineal peptide biology, CNS signaling, neuroprotective pathway models, and peptide-fragment response systems
We recommend 2 capsules daily with meals for best results